Accelerator Awards support investigators working together on ambitious four-year neuroendocrine cancer research projects, bringing diverse scientific expertise together to transform research and treatment.
Funder: Neuroendocrine Tumor Research Foundation
Due Dates (Anticipated): March 2027 (Competitive LOI) | June 2027 (Full proposal, by invitation)
Funding Amounts: $800,000 over four years ($200,000 per year), paid in US dollars
Summary: Supports ambitious, collaborative four-year projects with the potential to transform neuroendocrine cancer research and treatment.
Key Information: Applicants must hold an MD, PhD, MD/PhD, or equivalent degree and an Assistant Professor-level faculty appointment or above (or equivalent).
The Neuroendocrine Tumor Research Foundation (NETRF) Accelerator Awards fund groundbreaking projects with the potential to transform neuroendocrine cancer research and treatment. As NETRF’s largest and most prestigious grant category, the program supports ambitious research that pushes the boundaries of innovation. Proposals must include substantial aims requiring four years to complete, with scope and impact comparable to an NIH R01 grant.
The program strongly encourages collaboration among investigators from diverse scientific backgrounds to drive cutting-edge discoveries and accelerate progress. Projects are often multidisciplinary, bringing complementary expertise to neuroendocrine cancer research. Funding is paired with ongoing review of scientific progress and milestones, followed by longer-term assessment of research outcomes.